CIK 0001287098 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522210438
- Phone
- 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 42 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-02 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −17,857 | 1 | ||
| 2024-08-01 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise 10b5-1 | +15,476 | $1.64 | $25K | 40,476 |
| 2024-08-01 | Ross Thomas M. EVP, GLOBAL SALES | Sale 10b5-1 | −15,476 | $4.54 | $70K | 25,000 |
| 2024-08-01 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −15,476 | 17,858 | ||
| 2024-07-26 | Johnston John Joseph Director | Option exercise 10b5-1 | +3,000 | $2.93 | $9K | 144,950 |
| 2024-07-26 | Johnston John Joseph Director | Sale 10b5-1 | −3,000 | $4.75 | $14K | 141,950 |
| 2024-07-26 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 10,396 | ||
| 2024-07-09 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise 10b5-1 | +13,531 | $1.64 | $22K | 38,531 |
| 2024-07-09 | Ross Thomas M. EVP, GLOBAL SALES | Sale 10b5-1 | −13,531 | $4.03 | $55K | 25,000 |
| 2024-07-09 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −13,531 | 33,334 | ||
| 2024-07-08 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise 10b5-1 | +19,802 | $1.64 | $32K | 44,802 |
| 2024-07-08 | Ross Thomas M. EVP, GLOBAL SALES | Sale 10b5-1 | −19,802 | $4.03 | $80K | 25,000 |
| 2024-07-08 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −19,802 | 46,865 | ||
| 2024-06-27 | Johnston John Joseph Director | Option exercise 10b5-1 | +5,044 | $1.64 | $8K | 146,994 |
| 2024-06-27 | Johnston John Joseph Director | Option exercise 10b5-1 | +4,956 | $2.93 | $15K | 151,950 |
| 2024-06-27 | Johnston John Joseph Director | Sale 10b5-1 | −10,000 | $3.99 | $40K | 141,950 |
| 2024-06-27 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −5,044 | 1,121 | ||
| 2024-06-27 | Johnston John Joseph Director | Option exercise · Stock Option (right to buy) 10b5-1 | −4,956 | 13,396 | ||
| 2024-06-20 | Ross Thomas M. EVP, GLOBAL SALES | Option exercise 10b5-1 | +33,333 | $1.64 | $55K | 58,333 |
| 2024-06-20 | Ross Thomas M. EVP, GLOBAL SALES | Sale 10b5-1 | −33,333 | $4.09 | $136K | 25,000 |
Page 6 of 15 · 282 trades